Oramed Pharmaceuticals Inc. (ORMP)
USD 2.4
(2.13%)
USD 2.4
(2.13%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -27.91 Million | -21.18 Million | -12.44 Million | -12.94 Million | -14.65 Million | -5.83 Million |
| Net Income | -37.76 Million | -22.98 Million | -11.51 Million | -14.35 Million | -12.72 Million | -10.48 Million |
| Depreciation & Amortization | 58 Thousand | 77 Thousand | 7000.00 | 8000.00 | 6000.00 | 5000.00 |
| Deferred income taxes | - | -689 Thousand | 1.01 Million | 254 Thousand | 22 Thousand | 124 Thousand |
| Stock-based compensation | 11.5 Million | 2.69 Million | 1.17 Million | 808 Thousand | 1.54 Million | 1.57 Million |
| Change in working capital | -943 Thousand | -1.31 Million | -3.15 Million | 290 Thousand | -3.6 Million | 2.87 Million |
| Other non-cash items | -778 Thousand | 1.04 Million | 38 Thousand | 55 Thousand | 99 Thousand | 72 Thousand |
| Investing Cash Flow | 30.21 Million | -23.76 Million | 4.62 Million | 11.25 Million | -7 Million | 4.3 Million |
| Investments in PPE | -496 Thousand | -375 Thousand | -82 Thousand | -15 Thousand | -5000.00 | -7000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -154.4 Million | -53.82 Million | -39.38 Million | -30.58 Million | -26.57 Million | -24.65 Million |
| Sales/Maturities of investments | 185.08 Million | 30.43 Million | 44.09 Million | 41.86 Million | 19.57 Million | 28.96 Million |
| Other Investing Activities | 26 Thousand | -1000.00 | -1000.00 | -3000.00 | -2000.00 | -3000.00 |
| Financing Cash Flow | 10.77 Million | 102.89 Million | 23.78 Million | - | 22.65 Million | 1.58 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 11.5 Million | 79.98 Million | 23.77 Million | - | 21.65 Million | 25 Thousand |
| Other Financing Activities | -721 Thousand | 22.9 Million | 13 Thousand | - | 997 Thousand | 1.56 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -376 Thousand | 2.06 Million | -816 Thousand | 501 Thousand | -612 Thousand | 1.25 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -567 Thousand | -3.37 Million | -2.34 Million | -211 Thousand | -2.99 Million | 1.61 Million |
| Cash at beginning of period | 27.45 Million | 19.29 Million | 3.32 Million | 4.99 Million | 3.96 Million | 3.9 Million |
| Cash at end of period | 40.46 Million | 77.24 Million | 19.29 Million | 3.32 Million | 4.99 Million | 3.96 Million |
| Capital Expenditure | -496 Thousand | -375 Thousand | -82 Thousand | -15 Thousand | -5000.00 | -7000.00 |
| Effect of forex changes on cash | -64 Thousand | 2000.00 | -5000.00 | 14 Thousand | 34 Thousand | 5000.00 |
| Net cash flow / Change in cash | 13 Million | 57.94 Million | 15.96 Million | -1.66 Million | 1.02 Million | 62 Thousand |
| Free Cash Flow | -28.41 Million | -21.55 Million | -12.52 Million | -12.95 Million | -14.66 Million | -5.83 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.28 Million | -1.31 Million | -3.61 Million | -37.76 Million | -8.73 Million | -7.25 Million |
| Depreciation & Amortization | 54 Thousand | 52 Thousand | 37 Thousand | 58 Thousand | 17 Thousand | 15 Thousand |
| Deferred income taxes | -2.6 Million | 2.53 Million | - | - | - | - |
| Stock-based compensation | 852 Thousand | 1.82 Million | 173 Thousand | 11.5 Million | 2.54 Million | 3.05 Million |
| Change in working capital | 1.81 Million | -3.24 Million | -816 Thousand | -943 Thousand | -1.55 Million | 2.44 Million |
| Other non-cash items | -134 Thousand | -2.47 Million | -1.33 Million | -778 Thousand | -339 Thousand | -495 Thousand |
| Investing Cash Flow | -75.12 Million | -14.71 Million | -13.2 Million | 30.21 Million | 11.26 Million | 1.22 Million |
| Investments in PPE | -32 Thousand | -20 Thousand | -199 Thousand | -496 Thousand | -308 Thousand | -121 Thousand |
| Acquisitions | 75.09 Million | - | -5.99 Million | - | - | - |
| Investment purchases | -101 Million | -70.91 Million | -19 Million | -154.4 Million | -40.2 Million | -7.2 Million |
| Sales/Maturities of investments | 25.91 Million | 56.22 Million | 5.99 Million | 185.08 Million | 51.75 Million | 8.54 Million |
| Other Investing Activities | - | - | 5.99 Million | 26 Thousand | 23 Thousand | 3000.00 |
| Financing Cash Flow | 74.54 Million | 19.81 Million | 2.43 Million | 10.77 Million | 4.17 Million | 4.31 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2000.00 | - | - | - | - | - |
| Common Stock Issuance | -2000.00 | - | 2.43 Million | 11.5 Million | 4.15 Million | 4.37 Million |
| Other Financing Activities | 74.55 Million | - | - | -721 Thousand | 20 Thousand | -64 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.72 Million | -3.22 Million | -103 Thousand | -376 Thousand | -46 Thousand | 724 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 91 Thousand | -21 Thousand | -713 Thousand | -567 Thousand | -1.5 Million | 1.71 Million |
| Cash at beginning of period | 6.76 Million | 24.1 Million | 40.46 Million | 27.45 Million | 33.19 Million | 29.89 Million |
| Cash at end of period | 5.46 Million | 6.76 Million | 24.1 Million | 40.46 Million | 40.46 Million | 33.19 Million |
| Capital Expenditure | -32 Thousand | -20 Thousand | -199 Thousand | -496 Thousand | -308 Thousand | -121 Thousand |
| Effect of forex changes on cash | -31 Thousand | 7000.00 | -38 Thousand | -64 Thousand | -105 Thousand | 3000.00 |
| Net cash flow / Change in cash | -1.29 Million | -17.33 Million | -16.36 Million | 13 Million | 7.26 Million | 3.3 Million |
| Free Cash Flow | -726 Thousand | -2.65 Million | -5.74 Million | -28.41 Million | -8.37 Million | -2.36 Million |
2524
UNI
HSHCY
BRIGADE
DLI
KLBN11